Assembly Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Assembly Biosciences

05/11/2021 17:03

* Assembly Biosciences Inc  ASMB.OQ  reported a quarterly
adjusted loss of 41 cents​​ per share for the quarter ended in
September. The mean expectation of six analysts for the quarter
was for a loss of 56 cents per share.
* Revenue fell 81.9% to $6.25 million from a year ago;  analysts
expected zero. 
* Assembly Biosciences Inc's reported EPS for the quarter was a
loss of 41 cents​.
* The mean earnings estimate of analysts had risen by about 1.4%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Assembly Biosciences Inc shares had fallen by 8.9% this
quarter and lost 47.6% so far this year.
* The company reported a quarterly loss of $18.8 million.
* Wall Street's median 12-month price target for Assembly
Biosciences Inc is $10.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 5 at 05:03 p.m.
 ​All figures in US dollars unless otherwise stated